Sublingual Versus Endovenous Fentanyl for the Prehospital Analgesia in Patients With Limb Trauma on the Slope

NCT ID: NCT03080350

Last Updated: 2020-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Study Completion Date

2018-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the non-inferiority of the efficacy for prehospital analgesia of sublingual administered fentanyl versus endovenous administered fentanyl for patients with limb trauma on the slope

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fentanyl endovenous (ev) is an excellent analgesic drug for pain relief in acute traumatic pain. Fentanyl sublingual (Abstral ®) is an excellent analgesic drug in the breakthrough cancer pain relief in oncologic patients.

The immediate (less than 10 minutes) effect and the ease of administration of sublingual fentanyl is a feasible drug administration for immediate analgesia in remote areas such as mountain rescue missions eg. the slope.

Patients will be recruited according to a randomized list to fentanyl ev or fentanyl sublingual versus placebo oral or placebo ev.

Safety issues like control of vital signs will be warranted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Pain Due to Trauma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fentanyl sublingual + Placebo ev

Fentanyl 100 µg sublingual in acute sever pain + NaCl 0,9% endovenous to mimic fentanyl ev

Group Type EXPERIMENTAL

Fentanyl sublingual

Intervention Type DRUG

Fentanyl sublingual

Placebo ev

Intervention Type DRUG

Placebo - NaCL 0,9% ev

Fentanyl ev + Placebo sublingual

Fentanyl ev in acute sever pain + Sugar pill manufactured to mimic fentanyl sublingual

Group Type ACTIVE_COMPARATOR

Fentanyl ev

Intervention Type DRUG

Fentanyl ev

Placebo sublingual

Intervention Type DRUG

Placebo sublingual

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fentanyl sublingual

Fentanyl sublingual

Intervention Type DRUG

Fentanyl ev

Fentanyl ev

Intervention Type DRUG

Placebo sublingual

Placebo sublingual

Intervention Type DRUG

Placebo ev

Placebo - NaCL 0,9% ev

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Abstral

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Trauma on the limbs with a pain score of 4 or more on the slope
* ASA I - II

Exclusion Criteria

* children (\< 18 years)
* cognitive impairment: brain injury, intoxication, analgesia
* weight under 50 kg and more than 100 kg
* other injuries like chest trauma with respiratory insufficiency, suspect liver or spleen injury, amputation;
* chronic analgesic use or misuse
* allergy
* fear of needles
* pregnancy
* speech difficulties
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institute of Mountain Emergency Medicine

OTHER

Sponsor Role collaborator

Azienda Sanitaria dell'Alto Adige

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Elisabeth Gruber

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rosmarie Oberhammer, MD

Role: PRINCIPAL_INVESTIGATOR

Südtiroler Sanitätsbetrieb - Bruneck Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Skiresort - Kronplatz

Bruneck, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SABES Pain 2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nasal Fentanyl And Renal Colic
NCT01339624 COMPLETED NA